TuHURA BIOSCIENCES, INC./NV Weighted Average Number of Shares Outstanding, Basic and Diluted
TuHURA BIOSCIENCES, INC./NV (HURA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 32.47 million shares for the 6-month period ending 2014-06-30, per its 10-K filed 2014-08-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2014-08-28
- TuHURA BIOSCIENCES, INC./NV weighted average number of shares outstanding, basic and diluted for the quarter ending 2014-06-30 was 33.28M shares, a 7.44% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV weighted average number of shares outstanding, basic and diluted for the quarter ending 2014-03-31 was 31.66M shares, a 30.20% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV weighted average number of shares outstanding, basic and diluted for the quarter ending 2013-06-30 was 30.97M shares, a 116.28% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV weighted average number of shares outstanding, basic and diluted for the quarter ending 2013-03-31 was 24.32M shares, a 93.58% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV weighted average number of shares outstanding, basic and diluted for fiscal 2013 was 29.67M shares, a 124.20% increase from fiscal 2012.
- TuHURA BIOSCIENCES, INC./NV weighted average number of shares outstanding, basic and diluted for fiscal 2012 was 13.23M shares, a 55.17% increase from fiscal 2011.
- TuHURA BIOSCIENCES, INC./NV weighted average number of shares outstanding, basic and diluted for fiscal 2011 was 8.53M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 0 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2014-06-30 | 33.28M shares derived: 10-K 6 month − 10-Q 3 month · filed 2014-08-28 | 32.47M shares 10-K · filed 2014-08-28 | |||
| 2014-03-31 | 31.66M shares 10-Q · filed 2014-05-15 | ||||
| 2013-12-31 | 29.67M shares 10-K · filed 2014-08-28 | ||||
| 2013-06-30 | 30.97M shares 10-Q · filed 2013-08-12 | 27.73M shares 10-K · filed 2014-08-28 | 19.74M shares derived: average of 3 quarters · filed 2014-05-15 | 15.79M shares derived: average of 4 quarters · filed 2014-05-15 | |
| 2013-03-31 | 24.32M shares 10-Q · filed 2014-05-15 | 14.13M shares derived: average of 2 quarters · filed 2014-05-15 | 10.73M shares derived: average of 3 quarters · filed 2014-05-15 | 11.63M shares derived: average of 4 quarters · filed 2014-05-15 | |
| 2012-12-31 | 3.94M shares 10-Q · filed 2013-01-18 | 5.21M shares 10-Q · filed 2013-01-18 | 7.40M shares derived: average of 3 quarters · filed 2013-08-12 | 13.23M shares 10-K · filed 2014-08-28 | |
| 2012-09-30 | 3.94M shares 10-Q/A · filed 2012-12-20 | 9.13M shares derived: average of 2 quarters · filed 2013-08-12 | 10.28M shares derived: average of 3 quarters · filed 2013-08-12 | 8.69M shares derived: average of 4 quarters · filed 2013-08-12 | |
| 2012-06-30 | 3.94M shares 10-K/A · filed 2012-12-20 | 14.32M shares 10-Q · filed 2013-08-12 | 13.44M shares 10-Q · filed 2013-08-12 | 10.28M shares derived: average of 3 quarters · filed 2013-08-12 | 9.19M shares derived: average of 4 quarters · filed 2013-08-12 |
| 2012-03-31 | 12.56M shares 10-Q · filed 2013-05-15 | 8.25M shares derived: average of 2 quarters · filed 2013-05-15 | 7.49M shares derived: average of 3 quarters · filed 2013-05-15 | ||
| 2011-12-31 | 3.94M shares 10-Q · filed 2013-01-18 | 3.94M shares 10-Q · filed 2013-01-18 | 8.53M shares 10-K · filed 2014-03-10 | ||
| 2011-09-30 | 5.95M shares 10-Q/A · filed 2012-12-20 | ||||
| 2011-06-30 | 5.95M shares 10-K/A · filed 2012-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |